Webinar: "A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study”

This year, on ME/CFS Awareness Day, Solve announced ME/CFS Catalyst Award funding for Dr. Jay H. Chung (National Institutes of Health) in support of his study, "Mitochondrial stabilizer IVO-21 as therapy for ME/CFS."
 
The study tests a low-cost pill medication called IVO in preclinical mouse models to see if it boosts cellular energy and reduces inflammation—mechanisms believed to drive symptoms such as fatigue and brain fog. 

On Tuesday, September 8, Solve will host Dr. Chung for the free educational webinar,  “A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study.” 

In conversation with Solve's Vice President of Scientific Programs, Dr. Jessica Maya, Dr. Chung will discuss why his research is an essential step toward future clinical studies that could benefit millions, and explain how it could pave the way for a treatment that addresses the root causes of ME/CFS and associated complex chronic diseases.
 

When:
Tuesday, September 8, 2026
3:00-4:00 pm PT / 6:00-7:00 pm ET

Register Here